Skip to main content
logo
INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.870
+0.040 (2.19%)
At close: Oct 14, 2025, 4:00 PM EDT
1.860
-0.010 (-0.53%)
After-hours: Oct 14, 2025, 6:52 PM EDT

INmune Bio Revenue

INmune Bio had revenue of $50.00K in the twelve months ending June 30, 2025, down -41.18% year-over-year. In the year 2024, INmune Bio had annual revenue of $14.00K, down -90.97%.

Revenue (ttm)
$50.00K
Revenue Growth
-41.18%
P/S Ratio
973.02
Revenue / Employee
$2,273
Employees
22
Market Cap
49.71M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202414.00K-141.00K-90.97%
Dec 31, 2023155.00K-219.00K-58.56%
Dec 31, 2022374.00K193.00K106.63%
Dec 31, 2021181.00K170.00K1,545.45%
Dec 31, 202011.00K--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

INMB News

More News